ClinicalTrials.gov
ClinicalTrials.gov Menu

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003176
Recruitment Status : Unknown
Verified January 2007 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
First Posted : April 7, 2004
Last Update Posted : December 16, 2008
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)